Burning pain: Axonal dysfunction in erythromelalgia
Journal
Pain
Journal Volume
158
Journal Issue
5
Pages
900-911
Date Issued
2017
Author(s)
Abstract
Erythromelalgia (EM) is a rare neurovascular disorder characterized by intermittent severe burning pain, erythema, and warmth in the extremities on heat stimuli. To investigate the underlying pathophysiology, peripheral axonal excitability studies were performed and changes with heating and therapy explored. Multiple excitability indices (stimulus-response curve, strength-duration time constant (SDTC), threshold electrotonus, and recovery cycle) were investigated in 23 (9 EMSCN9A+ and 14 EMSCN9A-) genetically characterized patients with EM stimulating median motor and sensory axons at the wrist. At rest, patients with EM showed a higher threshold and rheobase (P < 0.001) compared with controls. Threshold electrotonus and current-voltage relationships demonstrated greater changes of thresholds in both depolarizing and hyperpolarizing preconditioning electrotonus in both EM cohorts compared with controls in sensory axons (P < 0.005). When average temperature was raised from 31.5°C to 36.3°C in EMSCN9A+ patients, excitability changes showed depolarization, specifically SDTC significantly increased, in contrast to the effects of temperature previously established in healthy subjects (P < 0.05). With treatment, 4 EMSCN9A+ patients (4/9) reported improvement with mexiletine, associated with reduction in SDTC in motor and sensory axons. This is the first study of primary EM using threshold tracking techniques to demonstrate alterations in peripheral axonal membrane function. Taken together, these changes may be attributed to systemic neurovascular abnormalities in EM, with chronic postischaemic resting membrane potential hyperpolarization due to Na + /K + pump overactivity. With heating, a trigger of acute symptoms, axonal depolarization developed, corresponding to acute axonal ischaemia. This study has provided novel insights into EM pathophysiology. ? Copyright 2017 The Author(s).
Subjects
Erythromelalgia; Excitability; Mexiletine; Pain; SCN9A; Sodium channel
SDGs
Other Subjects
acetylsalicylic acid; amitriptyline; antihistaminic agent; carbamazepine; clonazepam; clonidine; gabapentin; imipramine; mexiletine; midodrine; misoprostol; phenoxybenzamine; pregabalin; propranolol; SCN9A protein, human; sodium channel Nav1.7; adenosine triphosphatase (potassium sodium); sodium channel Nav1.7; adolescent; adult; aged; Article; axon; axonal injury; burning pain; child; clinical article; controlled study; depolarization; electric potential; erythromelalgia; excitability; heating; human; hyperpolarization; male; membrane steady potential; nerve fiber membrane; pain; pathophysiology; priority journal; stimulus response; temperature; biological model; case control study; complication; computer simulation; erythromelalgia; female; genetics; middle aged; mutation; nerve conduction; pain; pathology; physiology; severity of illness index; young adult; axon; clinical feature; cohort analysis; electrical potential parameters; gene mutation; mathematical model; molecular pathology; motor nerve; motor nerve conduction; muscle action potential; nerve excitability; nerve stimulation; peripheral nerve; preschool child; recovery cycle; sensory nerve; strength duration time constant; threshold electrotonus; wrist; Adolescent; Adult; Aged; Axons; Case-Control Studies; Child; Computer Simulation; Erythromelalgia; Female; Humans; Male; Middle Aged; Models, Biological; Mutation; NAV1.7 Voltage-Gated Sodium Channel; Neural Conduction; Pain; Severity of Illness Index; Temperature; Young Adult
Publisher
Lippincott Williams and Wilkins
Type
journal article